May 2025

Neuroplast participated in the international Neuroscience weel 2025 at the COBRAIN Scientific-Educational Center in Yernevan, Armenia. From 2023 on, Yernevan Armenia, Astana Kazakhstan and Oxford participate in the Alzheimer's Disease research studies of Neuroplast.

​

April 2025

Neuroplast joins LSX World Congress Europe on 29 and 30 APRIL 2025

​

March 2025

Neuroplast attends ATMP Advanced Therapies Conference on 18 and 19 MARCH 2025

​

September 2024

Neuroplast stages at the Scientific Meeting of the International Spinal Cord Society on 22-25 SEPTEMBER 2024

​

June 2024

Neuroplast successfully concludes the Neuro-Cells® Phase 2 trial for Spinal Cord Injury.

​

June 2024

Neuroplast adds Alzheimer’s Disease to the Neuro-Cells® portfolio. 

​

February 2024

Neuroplast core team restarts activities. 

​

November 2023

Neuroplast resumes lab activities for next financing round.

​

November 2023

Dutch national competent authorities (IGJ) confirm Neuroplast’s GMP compliance.